Zoloft Heart Defects Information

What is Zoloft?

Zoloft is an antidepressant drug used to treat a variety of depression and anxiety-related emotional and mood disorders. Zoloft (generic name sertraline hydrochloride) is a member of a class of drugs called Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants. SSRIs work by increasing serotonin levels in the body. Serotonin is a natural substance in the brain that helps maintain mental balance.

Zoloft (sertaline HCL) was first approved by the FDA in 1991 and introduced to the market by the drug company Pfizer. In 2005, its last year before going generic, Zoloft sales totaled $3.3 billion.

No fee unless we collect. We represent families affected by Zoloft heart defects on a contingency fee basis. There is never an attorney fee unless and until our lawyers collect money for you on your Zoloft heart defects claim. Contact us now for a free, no-obligation consultation with an experienced Zoloft lawsuit attorney. 800-845-6913

Pfizer’s patent expired on Zoloft expired in 2006. Since then, generic versions of Zoloft (sertaline HCL) also have been available by prescription in the Unites States. By 2007, it was the most prescribed antidepressant drug on the market, with nearly 30 million prescriptions.

What are the most common Zoloft heart defects?

Septal defects, ASD and VSD, are the most common Zoloft heart defects. The septum is the wall between the left and right sides of the heart. A septal defect is a malformation of the septum that leaves a hole between the two sides of the heart. Septal defect commonly are referred to as “a hole in the heart.”

An Atrial Septal Defect (ASD) is a hole in the wall that separates the two upper chambers (atria) of the heart. A Ventricular Septal Defect (VSD) is a hole in the wall between the lower chambers (ventricles) of the heart.

Have other heart defects been linked to Zoloft use while pregnant?

Zoloft use during pregnancy has been linked to the following heart defects:

Most Zoloft heart defects are septal defects (ASD and VSD).

What has the FDA done about Zoloft heart defects?

On December 8, 2005, a FDA Safety Alert for Zoloft and other SSRI antidepressant medications was issued. The FDA drug alert was based on two studies that showed women who took Zoloft during the 1st trimester of pregnancy were 100%-150% more likely to have a baby with septal heart defects (ASD or VSD) compared with women who did not take Zoloft or another SSRI while pregnant.

On July 19, 2006, a FDA Zoloft Pubic Health Advisory was issued after a study was published linking the use of Zoloft and other SSRI antidepressants while pregnant to an increased risk of Primary Pulmonary Hypertension of the Newborn (PPHN). The study showed that babies born to women who took Zoloft or other SSRIs after the 20th week of the pregnancy (second half of pregnancy and the 3rd trimester) were at a 600% increased PPHN risk than babies born of a pregnancy in which no SSRI drug was taken.

Do I have a Zoloft heart defects lawsuit?

If you or a loved one may have a Zoloft birth defect lawsuit claim, contact us today for a free no-obligation consultation with a top Zoloft heart defects lawsuit attorney. Our birth injury lawyers pursue Zoloft lawsuits to recover financial compensation for families and children affected by Zoloft heart defects.